Related Experiment Video
Updated: Jan 29, 2026
10:26
Monitoring Cell-to-cell Transmission of Prion-like Protein Aggregates in Drosophila Melanogaster
Published on: March 12, 2018
8.4K
A Novel Therapy for Huntington's Disease
Cerebrum : the Dana Forum on Brain Science
|February 13, 2019
Summary
Researchers identified the gene for Huntington's disease, a fatal neurodegenerative disorder. A new gene-silencing strategy may offer future therapies for Huntington's and similar conditions.
Area of Science:
- Neurogenetics
- Molecular Biology
- Pharmacology
Background:
- Huntington's disease is a fatal, inherited neurodegenerative disorder.
- The disease gene was identified on human chromosome 4 in 1993.
- Current research focuses on developing treatments to manage the disease before symptom onset.
Purpose of the Study:
- To explore novel therapeutic strategies for Huntington's disease.
- To investigate the potential of gene-targeting approaches for neurodegenerative diseases.
Main Methods:
- Gene identification through family studies in Venezuela.
- Exploration of gene-silencing mechanisms.
Main Results:
- Identification of the Huntington's disease gene on chromosome 4.
- Emerging potential of gene-targeting strategies.
Conclusions:
- Gene identification was a critical step towards understanding Huntington's disease.
- Targeted gene-silencing presents a promising therapeutic avenue for Huntington's and other neurodegenerative disorders.